Shelf-stable powdered or liquid composition comprising n-acetyl-cysteine and glycine with improved palatability
A novel food composition combining NAC, glycine, and natural ingredients enhances palatability and stability, addressing sensory drawbacks and user compliance in high-dose oral administration.
Patent Information
- Application Number
- PCT/EP2026/063256
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-09
- Filing Date
- 2026-05-07
- Publication Date
- 2026-11-12
AI Technical Summary
Existing NAC and glycine compositions suffer from poor palatability, including sulfurous odor, bitterness, and astringency, making high-dose oral administration cumbersome and reducing user compliance, while lacking effective stabilization and shelf-stability.
A functional food composition combining NAC, glycine, dried biomass of Spinacia and Chlorella, cinnamon, steviol glycosides, and thaumatin or sucralose, which masks odors and tastes, and uses natural antioxidants for stabilization, eliminating synthetic preservatives.
The composition achieves improved palatability, stability, and user-friendly high-dose administration, maintaining sensory acceptability and extending shelf-life without synthetic additives.
Smart Images

Figure IMGF000009_0001_TABLE 
Figure IMGF000009_0002_TABLE 
Figure IMGF000010_0001_TABLE
Abstract
Description
[0001] P138691PC00
[0002] Title: SHELF-STABLE POWDERED OR LIQUID COMPOSITION COMPRISING N-ACETYL-CYSTEINE AND GLYCINE WITH IMPROVED PALATABILITY
[0003] FIELD OF THE INVENTION
[0004] The disclosure relates to functional food compositions comprising N- acetylcysteine (NAC) and glycine, and their use in supporting mitochondrial function, oxidative resilience and / or healthy metabolic function in an individual. The compositions are designed to improve palatability and shelf-stability of NAC-containing formulations, allowing for high-dose oral administration in a user-friendly powdered format. The compositions are particularly suitable for promoting physiological functions relevant to aging, such as maintenance of redox balance, low-grade inflammation, and endothelial health.
[0005] BACKGROUND OF THE INVENTION
[0006] Biological aging represents a pivotal target for interventions aimed at enhancing health span (i.e. the period of life spent in good health), yet the scientific and therapeutic exploration of this field remains at an early stage. Although certain interventions, including caloric restriction and pharmacological agents such as rapamycin, have demonstrated potential in modulating the aging process, the underlying biological complexity of aging, characterized by numerous interrelated pathways, continues to present considerable challenges to the development of effective, targeted therapies.
[0007] Aging is widely recognized as the primary driver of numerous chronic diseases and functional decline. This necessitates a transition from conventional, reactive models of disease management ("disease-care") to proactive strategies focused on preserving and promoting overall physiological resilience ("true health-care"). Within this context, emerging evidence underscores a strong link between metabolism and inflammation. Enhancing metabolic health has been shown to ameliorate inflammatory biomarkers and mitochondrial dysfunction, both of which are key contributors to aging and age-associated pathologies.Glycine and N- acetylcysteine (NAC) are compounds known in the art for their roles in mitigating oxidative stress, reducing low-grade inflammation, and preserving mitochondrial integrity. These effects have been associated with attenuation of age-related declines in muscle strength, cognitive performance, and immune function. Preclinical and clinical studies suggest that the administration of glycine and NAC can reverse specific molecular and functional hallmarks of aging.
[0008] Particularly, glycine and cysteine serve as precursors of the biosynthesis of glutathione (GSH), a critical intracellular antioxidant whose levels decline with age, thereby contributing to elevated oxidative stress and cellular damage. NAC, a stable and bioavailable derivative of cysteine, and glycine play complementary roles in restoring GSH levels. Moreover, cysteine or NAC contributes sulfur moieties necessary for vital metabolic and signaling processes, while glycine is integral to protein synthesis, nucleic acid (DNA / RNA) production, and neurotransmission.
[0009] NAC and glycine were observed to show independent benefits. NAC enhances muscle performance and may confer cognitive benefits in frail elderly individuals. Glycine, in turn, has demonstrated the ability to extend both lifespan and health span in animal models. Moreover, the combined supplementation of NAC and glycine is known for exerting synergistic effects, notably in more effectively enhancing GSH levels, reducing oxidative stress, suppressing inflammatory responses, and improving cardiovascular health by supporting endothelial function and reducing cardiac oxidative damage.
[0010] The synergistic impact of NAC and glycine also extends to modulation of pathways such as the NOD-like receptor protein 3 (NLRP3) inflammasome, a central regulatory node implicated in age-related inflammation and cellular senescence. Inhibition of NLRP3 activity has been associated with improved mitochondrial function, enhanced autophagic processes, and reduced inflammatory signaling. Evidence suggests that glycine and NAC influence these processes through modulation of upstream regulators such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and thioredoxin-interacting protein (TXNIP). The pleiotropic effects of glycine and NAC on inflammation, oxidative stress, and mitochondrial function, are likelymediated, at least in part, via NLRP3. Targeting NLRP3 has demonstrated the ability to extend both health span and lifespan and represents a promising target for multiple hallmarks of aging. Further, NAC-derived cysteine is known to be involved in the biosynthesis of taurine, a pathway implicated in extending lifespan in mice and enhancing healthspan in rhesus monkeys.
[0011] Thus, the combination of glycine and NAC targets multiple hallmarks of aging, including oxidative stress, inflammation, and mitochondrial dysfunction, offering a promising, multifaceted approach to enhancing healthspan and lifespan.
[0012] In the prior art, the term " GlyNAC" refers to a combination of glycine and N-acetylcysteine (NAC), typically administered in capsule form. GlyNAC has been described in the scientific and patent literature (e.g., Sekhar et al., US8362080B2) for its potential to restore intracellular glutathione (GSH) levels and improve various physiological functions associated with aging. These formulations are generally focused on therapeutic or nutraceutical applications and do not address formulation challenges associated with daily, high-dose use in a food-grade context.
[0013] The present functional food composition comprises NAC and glycine together with a proprietary blend of flavoring agents, whole biomass materials (e.g., dried biomass of Spinacia genus and / or Chlorella genus), and / or specific non-caloric sweeteners, preferably specific natural non-caloric sweeteners. This composition enables high-dose oral delivery while reducing sensory drawbacks typically associated with NAC, such as sulfurous odor, bitterness, and astringency. It further avoids the use of synthetic preservatives.
[0014] The observed stabilization of NAC in this composition is believed to result from naturally occurring antioxidant compounds within the whole biomass (e.g. dried biomass of Spinacia genus and / or Chlorella genus), such as polyphenols, carotenoids, and chlorophyll derivatives. These compounds may act as radical scavengers and contribute to reduced NAC oxidation, primarily to di-N- acetylcystine (diNAC), a disulfide-linked dimer that is the major degradation product of NAC under oxidative conditions. In contrast to conventional formulations that rely on purified antioxidantslike ascorbic acid, this approach makes use of the antioxidant environment provided by the unprocessed biomass matrix, which has not previously been described in the context of NAC-containing powdered compositions.
[0015] These technical features are relevant for sustained, long-term daily use of NAC and glycine as part of a functional food aimed at supporting healthspan, particularly in older adults. None of the prior art compositions teaches or suggests a formulation that combines high-dose NAC and glycine with improved sensory characteristics, oxidative stability, and food- grade compliance.
[0016] While compositions comprising glycine and NAC have a variety of health benefits, their oral administration is frequently associated with significant drawbacks that hinder user compliance. Specifically, due to its chemical structure NAC suffers from poor organoleptic properties such as a very distinctive sulfurous odor, astringency, and a bitter taste.
[0017] To mitigate these sensory drawbacks, conventional composition comprising NAC and glycine are often provided in encapsulated form. Nevertheless, individuals requiring or wishing to consume higher dosages must consume multiple capsules daily, which can be burdensome and have significant negative impact on compliance.
[0018] It is an object of the present invention to overcome these challenges and provide a novel and improved compositions comprising glycine and NAC.
[0019] SUMMARY OF THE INVENTION
[0020] The following are preferred embodiments of the disclosure.
[0021] 1. Afunctional food composition comprising N- acetylcysteine (NAC); glycine; a dried biomass of Spinacia genus, Chlorella genus and / or Arthrospira genus; cinnamon; optionally grapefruit aroma; optionally lemon flavor; one or more steviol glycosides; and thaumatin or sucralose.
[0022] 2. The composition according to embodiment 1, wherein the composition comprises 20-40 wt.% of NAC, 20-40 wt.% of glycine, 3-35 wt.% of said dried biomass, 0.3-9 wt.% ofcinnamon, 0.03-2 wt.% of grapefruit aroma, 0.03-2 wt.% of lemon flavor, 0.02-1.3 wt.% of one or more steviol glycosides, and 0.05-0.667% of thaumatin.
[0023] 3. The composition according to embodiment 1, wherein the composition comprises 20-40 wt.% of NAC, 20-40 wt.% of glycine, 3-35 wt.% of said dried biomass, 0.3-9 wt.% of cinnamon, 0-0.5% wt.% of grapefruit aroma, 0.03-2 wt.% of lemon flavor, 0.02-0.5 wt.% of one or more steviol glycosides, and 0.1%-0.5% of sucralose.
[0024] 4. The composition according to any one of the preceding embodiments, wherein the steviol glycoside is a rebaudioside, preferably selected from any one of rebaudioside A, rebaudioside M, rebaudioside D, or combination thereof, more preferably rebaudioside M.
[0025] 5. The composition according to any one of the preceding embodiments, wherein cinnamon is selected from any one of Cinnamomum verum, Cinnamomum cassia, Cinnamomum burmanni, or a combination thereof, preferably Cinnamomum verum.
[0026] 6. The composition according to any one of the preceding embodiments, wherein the composition comprises between 20-40 wt.% of NAC, preferably between 25-35 wt.% of NAC, such as 33 wt.% of NAC.
[0027] 7. The composition according to any one of the preceding embodiments, wherein the composition is a solid composition, preferably in a form of any one of powder, granule, pellets, tablet, or agglomerates.
[0028] 8. The composition according to any one of the preceding embodiments, wherein the composition does not comprise one or more of the following: ascorbic acid, acesulfame potassium, aspartame, calcium disodium EDTA, glucose, sulfite, maltodextrin, monk fruit extract, potassium benzoate, potassium phosphate, potassium citrate, potassium sorbate, sodium phosphate, or sodium selenite.
[0029] 9. A sachet comprising 3-6 g, preferably 4-5 g of the composition according to any one of embodiments 1-8.
[0030] 10. A liquid beverage comprising 3-6 g, preferably 4-5 g of the composition according to any one of embodiments 1-8.
[0031] 11. A method of preparing the liquid beverage of embodiment 10 comprising mixing the composition with liquid, wherein the liquid beverage comprises 1g composition per 4- 100ml of liquid, preferably wherein the liquid is water, fruit juice, milk-based drink, or tea.12. A non-therapeutic use of the composition of any one of the preceding embodiments for improving or supporting mitochondrial function, oxidative resilience, or healthy metabolic function in an individual.
[0032] 13. The non-therapeutic use according to embodiment 12, wherein 7-14 grams of the composition is administered daily.
[0033] 14. The composition according to any one of embodiments 1-8, having improved palatability for oral administration of NAC, preferably oral administration of high-concentration NAC, including reduced sulfurous odor, bitterness, and / or metallic taste.
[0034] 15. The composition according to any one of embodiments 1-8, wherein the inclusion of whole plant biomass, preferably dried biomass of Spinacia genus and / or Chlorella genus contributes to the stabilization of N- acetylcysteine (NAC) by reducing its oxidative degradation, in particular its conversion to diNAC.
[0035] 16. The composition according to any one of embodiments 1-8, having improved shelflife stability.
[0036] BRIEF DESCRIPTION OF THE DRAWINGS
[0037] Figure 1. Normalized two-paw grip strength in aged male C57BL / 6J mice after 7 weeks of dietary intervention. Mice receiving Formulation 1, specifically the 1:1:1 composition of glycine, NAC, and the flavor-masking proprietary blend, demonstrated significantly higher grip strength compared to control mice receiving the flavormasking proprietary blend alone (p = 0.033). This improvement in grip strength indicates a functional benefit of the Formulation 1, supporting its potential role in preserving or enhancing muscle function during aging.
[0038] Figure 2. Normalized four-paw grip strength in aged male C57BL / 6J mice following 7 weeks of dietary treatment. Mice treated with Formulation 1, specifically the 1:1:1 composition of glycine, NAC, and the flavor-masking proprietary blend exhibited higher four-paw grip strength compared to the control group receiving only the flavormasking proprietary blend. Grip strength was assessed using a digital force gauge and normalized to body weight. The observed improvement further supports the functional benefits of the Formulation 1 in maintaining or enhancing neuromuscular performance in aged mice.Figure 3. Plasma concentrations of interleukin-6 (IL-6) in aged male C57BL / 6J mice following 8 weeks of dietary intervention. IL-6 was measured via ELISA at the end of the study (week 8). In the treatment group, receiving Formulation 1 (i.e. the 1:1:1 composition of glycine, NAC, and the flavor-masking proprietary blend), IL-6 levels were below the detection limit of the assay in most samples. For graphical representation, values below the detection limit were conservatively set to the lower limit of detection (LOD). Despite this approach, treated animals displayed markedly lower IL-6 concentrations compared to controls, supporting a pronounced antiinflammatory effect of the composition.
[0039] DETAILED DESCRIPTION OF THE DISCLOSED EMBODIMENTS
[0040] The disclosure provides functional food composition comprising glycine and NAC. Such compositions are useful for, e.g., treating or preventing a number of disorders or conditions associated with aging, as well as for treating paracetamol overdose in an individual.
[0041] As described further herein, the composition as described herein may have several advantages over current formulations containing N- acetylcysteine (NAC) and glycine, including improved palatability, especially reduced sulfurous odor, reduced bitterness and / or reduced metallic taste, as well as offering an easy-to-drink beverage. This allows for user-friendly administration, especially for high dosages, and enhances user compliance. Furthermore, the compositions as described herein advantageously do not comprise synthetic preservatives.
[0042] In some embodiments, the functional food composition comprises N- acetylcysteine (NAC); glycine; a dried biomass of Spinacia genus, Chlorella genus and / or Arthrospira genus; cinnamon; one or more steviol glycosides; and thaumatin or sucralose. The functional food composition may further comprise lemon flavor and / or grapefruit aroma, as well as other flavoring agents such as mango, passion fruit, peach, tropical fruit, berry, apple or pear.
[0043] In some embodiments, the functional food composition comprises N- acetylcysteine (NAC); glycine; a dried biomass of Spinacia genus, Chlorella genus and / or Arthrospiragenus; cinnamon; one or more steviol glycosides; and thaumatin. The functional food composition may further comprise lemon flavor and / or grapefruit aroma.
[0044] In some embodiments, the functional food composition comprises N- acetylcysteine (NAC); glycine; a dried biomass of Spinacia genus, Chlorella genus and / or Arthrospira genus; cinnamon; one or more steviol glycosides; and sucralose. The functional food composition may further comprise lemon flavor and / or grapefruit aroma.
[0045] The composition comprises between 20-40 wt.% of NAC, preferably between 25-35 wt.% of NAC, such as 33 wt.% of NAC. The composition comprises between 20-40 wt.% of glycine, preferably between 25-35 wt.% of glycine, such as 33 wt.% of glycine.
[0046] In preferred embodiments, the functional food composition comprises similar or essentially the same amount of NAC and glycine. The “essentially the same” is understood to mean that the amounts of NAC and glycine are substantially equal by weight, allowing for minor manufacturing tolerances or formulation variability. For example, the weight ratio of NAC to glycine may be from 0.7:1 to 1.3:1, preferably from 0.9:1 to 1.1:1, more preferably 1:1 such as 33 wt.% NAC and 33 wt.% glycine. In other words, the amount of NAC and glycine in the composition may each independently range from 20-40% by weight of the total composition, wherein the absolute difference between the amount of NAC and glycine does not exceed 10%, preferably 5%, more preferably 2% by weight.
[0047] In some embodiments, the weight ratio of NAC to glycine to the proprietary blend in the functional food composition as disclosed herein is from 1:1:0.5 to 1:1:1.5. As used herein, the term “proprietary blend” (or “proprietary mix”) refers to a mixture of substances of a composition as disclosed herein other than NAC and glycine. For example, said ratio may be 1: 1:0.5 such as 40 wt.% NAC, 40 wt.% glycine and 20 wt.% proprietary blend, 1: 1:0.8 (i.e. 35 wt.% NAC, 35 wt.% glycine, 30 wt.% proprietary blend), 1:1:1 (i.e. 33.3 wt.% NAC, 33.3 wt.% glycine, 33.3 wt.% proprietary blend), or 1:1: 1.3 (i.e. 30 wt.% NAC, 30 wt.% glycine, 40 wt.% proprietary blend). In preferred embodiments, the weight ratio of NAC to glycine to the proprietary blend is 1:1:1.In some embodiments, the proprietary blend comprises 5–15% dried biomass of Spinacia genus (e.g. dried spinach powder), 2–10% Chlorella biomass (e.g. dried Chlorella biomass), 0.2–0.8% lemon flavoring (e.g. natural lemon flavoring), and 0.05–1% or 0.05–0.3% steviol glycosides (e.g., Reb M), based on total weight of the functional food composition as described herein. The proprietary blend may further comprise natural aromatic compounds or flavoring agents such as grapefruit extract or citrus derivatives, which may contribute to perceived freshness, aroma, or bitterness modulation.
[0048] Preferably, a functional food composition comprises either thaumatin or sucralose. Exemplary compositions are described below as formula 1 and formula 2, comprising thaumatin or sucralose, respectively.
[0049] In some embodiments, the functional food composition comprises, consists, or consists essentially of the following
[0050]
[0051] In some embodiments, the functional food composition comprises, consists, or consists essentially of the following
[0052]
[0053]
[0054] In some embodiments, the functional food composition comprises, consists, or consists essentially of the following
[0055]
[0056] In some embodiments, the functional food composition comprises, consists, or consists essentially of the following
[0057]
[0058] In preferred embodiments, the functional food composition comprises, consists, or consists essentially of the following:
[0059]
[0060] In preferred embodiments, the functional food composition has the following composition:
[0061]
[0062]
[0063] In most preferred embodiments, the functional food composition has the following composition:
[0064]
[0065] In some embodiments the functional food composition has the following composition:
[0066]
[0067] The combination of NAC and glycine with the proprietary blend of the present composition as disclosed herein has a surprisingly improved palatability, especially when orally administered at high dosage. A functional food composition as disclosed herein exhibits significantly improved overall smell and taste profile of NAC and glycine composition.
[0068] In particular, one advantage of a functional food composition as disclosed herein is a reduced odor. In particular, the sulfur containing NAC makes conventional NAC and glycine compositions when dissolved in liquid strongly smell like rotten eggs. Said distinctive sulfurous odor of the existing compositions may result in an unpleasant experience during handling and consumption of said compositions. The functional food compositions as described herein as well as liquid preparations thereof as disclosed herein surprisingly have no or hardly any noticeable sulfurous odor.
[0069] Another advantage of a functional food composition as disclosed herein is reduced bitterness and / or astringency. NAC is known for having a strong bitter and astringent or metallic taste. This may further contribute to the unpleasant experience upon consumption of existing NAC and glycine compositions, especially if consumed at higher doses. The functional food compositions as disclosed herein advantageously exhibit reduced intensity of or hardly any noticeable bitter and / or metallic taste.
[0070] Furthermore, a functional food composition as disclosed herein allows for user-friendly administration, especially for high dose administration. For example, the functional food composition as described herein may be dissolved in water or other aqueous solutions thereby facilitating convenient integration into daily routines, such as consumption during mealtimes, eliminating the need for multiple capsules and enhancing user compliance.
[0071] As used herein, “N- acetylcysteine” also known as “acetylcysteine” or “NAC”, is well known to a skilled person and includes N-acetyl-L-cysteine (i.e. (2R)-2-acetamido-3-sulfanylpropanoic acid; CAS No. 616-91-1), N-acetyl-D-cysteine (i.e., (2R)-2-acetamido-3-sulfanylpropanoic acid; CAS No. 26117-28-2), and a mixture of N-acetyl-L-cysteine and N-acetyl-D-cysteine in any ratio. Preferably, NAC is N-acetyl-L-cysteine. NAC serves as a precursor of L-cysteine, a precursor of glutathione. NAC maybe obtained via chemical synthesis (e.g. acetylation of L-cysteine), or from commercially available sources. Preferably, NAC has a purity of at least 90%, at least 95%, more preferably at least 98%. Preferably, NAC is in a form of a fine powder.
[0072] As used herein, “glycine” refers to naturally occurring amino acid having CAS No. 56-40-6. As known to a skilled person, glycine acts as a precursor in the terminal step of glutathione biosynthesis. Thus, coadministration of NAC and glycine may significantly increase intracellular glutathione levels. Glycine further known to exert cytoprotective effects through modulation of inflammatory pathways and serves as an inhibitory neurotransmitter. Glycine may be obtained via protein hydrolysis, or via chemical synthesis. Glycine is also well known to a skilled person and is commercially available. Preferably, glycine has a purity of at least 90%, at least 95%, more preferably at least 98%.
[0073] In some embodiments, the functional food composition comprises a dried biomass of Spinacia genus, preferably of spinach (S. oleracea). In some embodiments, the functional food composition comprises a dried biomass of Chlorella genus. Chlorella is a genus of unicellular green algae. A dried biomass of Chlorella genus is a source of protein, fats, carbohydrates, fiber, chlorophyll, vitamins and minerals. In some embodiments, the functional food composition comprises a dried biomass of Arthrospira genus, preferably selected from A. platensis, A. maxima and / or A. fusiformis. Arthospira is a genus of filamentous cyanobacteria. An example of a dried biomass of Arthrospira genus is a commonly known spirulina primarily comprising A. platensis and. maxima, and optionally. fusiformis.
[0074] In some embodiments, the functional food composition comprises a dried biomass of combination of Chlorella genus and Arthrospira genus; Spinacia genus and Chlorella genus, Spinacia genus and Arthrospira genus; or combination of Spinacia genus, Chlorella genus and Arthrospira genus. In preferred embodiments, the composition comprises a dried biomass of Spinacia genus and Chlorella genus.A functional food composition as disclosed herein advantageously does not comprise synthetic preservatives while still exhibiting chemical stability. In some embodiments, it is hypothesized that a dried biomass of Spinacia genus, Chlorella genus and / or Arthrospira genus contributes to this stability by acting as an antioxidant matrix. Conventional stabilization strategies in NAC formulations typically rely on the use of purified compounds such as ascorbic acid to prevent oxidation.
[0075] In contrast, the present composition achieves stabilization without added purified antioxidants or synthetic preservatives. Without wishing to be bound by theory, it is believed that whole plant biomass, such as dried spinach or Chlorella, provides naturally occurring compounds (e.g., polyphenols, carotenoids, chlorophyll derivatives) that scavenge radicals and reduce NAC degradation. As shown in the Examples (Example 4), NAC-containing reference formulations without plant biomass developed a noticeable sulfurous odor during storage, whereas the present composition of the invention remained nearly odorless or was perceived as less intense by most observers. While di-N- acetylcystine (diNAC) is a known major degradation product of NAC under oxidative conditions, its levels were not quantified in this study. Therefore, the observed difference in odor cannot be directly linked to diNAC formation but may reflect differences in overall oxidative degradation.
[0076] Furthermore, as shown in Example 1 the stabilization effect of plant biomass (e.g. dried biomass of Spinacia and / or Chlorella genus) was observed under ambient storage conditions and is believed to result from the synergistic antioxidant and buffering properties of the biomass matrix. Such an effect has not been described previously in powdered food-grade NAC formulations.
[0077] In some embodiments, cinnamon is selected from any one of Cinnamomum verum, Cinnamomum cassia, Cinnamomum burmanni, or a combination thereof. Different cinnamon species may have different coumarin content and may differ in their smell and taste. For example, Cinnamomum verum (also commonly known as ceylon cinnamon) has lower coumarin content and milder taste. In preferred embodiments, cinnamon is Cinnamomum verum.Cinnamon is further known as having antioxidant properties and may act as complementary antioxidant source. In some embodiments, it is contemplated that cinnamon may contribute to the stabilization of labile bioactive compound such as NAC and / or support the overall antioxidant environment of a functional food composition as disclosed herein.
[0078] As used herein, the term “steviol glycosides” refers to a class of naturally occurring sweet-tasting compounds derived from the leaves of Stevia rebaudiana, comprising steviol molecules conjugated with one or more sugar moieties, including but not limited to glucose, rhamnose, xylose, or fructose. Steviol glycosides are main ingredients or precursors of many sweeteners marketed under the generic name stevia. Steviol glycosides are characterized by their intense sweetness ranging from 50 to 450 times sweeter than sucrose (table sugar), along with a non-caloric nature. Steviol glycosides do not induce a glycemic response when ingested because humans cannot metabolize stevia. Due to these properties, steviol glycosides are suitable as non-nutritive sweeteners in a variety of food products, beverages and pharmaceutical formulations. Steviol glycosides include, but are not limited to, rebaudioside A, rebaudioside B, rebaudioside C, rebaudioside D, rebaudioside M, dulcoside A and stevioside. Certain steviol glycosides are associated with a bitter and / or licorice-like aftertaste.
[0079] Rebaudioside A (also known as Reb A, CAS No. 58543-16-1) has a central steviol structure substituted with four glucose units and a high sweetness potency, 250-450 times sweeter than sucrose. Reb A is also known for having a bitter and / or licorice taste.
[0080] Rebaudioside M (also known as Reb M, CAS No. 1220616-44-3) contains six glucose units connected to the central steviol structure and has a sweetness potency of 200-350 times more than sucrose. Reb M is considered as having a clean and the most sucrose-like taste. Reb M advantageously does not have bitterness or licorice-like aftertaste.
[0081] Rebaudioside D (also known as Reb D, CAS No. 63279-13-0) contains five glucose units connected to the central steviol structure. Reb D offers a sweetness profile intermediate between Reb A and Reb M, with reduced bitterness and lingering compared to Reb A, though not as clean-tasting as Reb M.One or more steviol glycosides may be naturally derived (i.e. extracted from stevia leaves), semi- synthetic (e.g. obtained by enzymatic processes, or by fermentation) or synthetic (i.e. synthesized by chemical synthesis). One or more steviol glycosides may be purified. Purification methods are known in the art. Preferably, the one or more steviol glycosides has a purity of at least 80%, including at least 90%, preferably at least 95%, more preferably at least 98%. One or more steviol glycosides are preferably selected from any one of rebaudioside A, rebaudioside M, rebaudioside D, or a combination thereof, more preferably the steviol glycoside is rebaudioside M.
[0082] A functional food composition as disclosed herein further comprises a sweetener such as thaumatin or sucralose, preferably thaumatin.
[0083] The term “thaumatin” (also known as talin) as used herein refers to thaumatin I, thaumatin II, or combination thereof. Thaumatins are a class of sweet-tasting low-molecular weight proteins found in African katemfre fruit (Thaumatococcus daniellii). Thaumatin is approximately 1600-3200 times sweeter compared to sucrose (table sugar) with a slow onset of sweetness compared to other commercially low-caloric sweeteners and a long lasting perception. In some embodiments, the composition comprises from 0.025-0.7% or from 0.025-0.3 wt. % of thaumatin.
[0084] For example, thaumatin may enhance sweetness intensity and organoleptic balance of other sweeteners such as steviol glycosides. When used in combination with other sweeteners it may mask undesirable tastes (e.g. specific tastes from high-intensity steviol glycosides, bitterness such as from NAC, and / or metallic taste) and improve the overall flavor profile of a formulation. Commercially available thaumatin is typically a purified protein mixture of thaumatin I and thaumatin II. In some embodiments, thaumatin is thaumatin I. In some embodiments, thaumatin is thaumatin II. In preferred embodiments, thaumatin is a combination of thaumatin I and thaumatin II. Preferably, the thaumatin is food additive E 957 (a 2:1 ratio of thaumatin I and thaumatin II). Preferably, thaumatin is purified. In some embodiments, a highly potent or purified form of thaumatin (e.g., a single-component variant such as either thaumatin I or thaumatin II) may be used. If single-componentvariant is used, a lower concentration, such as 0.025–0.3 wt.% of thaumatin, may be sufficient to achieve the desired sweetening and flavor-masking effects.
[0085] Sucralose, also known as 4,1′,6′-trichloro-4,1,6′-trideoxy-galactosucrose and under the E number E955, is an artificial sweetener with a chemical formula C12H19Cl3O8and CAS No. 56038-13-2. Sucralose is about 600 times sweeter than sucrose and has a clean, sucrose-like taste without specific aftertaste.
[0086] A functional food composition as disclosed herein may optionally comprise one or more aromas (also referred herein as flavorings or flavors). The functional food composition as disclosed herein may comprise natural or artificial aromas, preferably natural aromas. In some embodiments, the composition comprises one or more aromas selected from fruity aromas, herbal aromas or citrus aromas, preferably citrus aromas. Examples of citrus aromas include grapefruit aroma, lemon aroma, orange aroma, and lime aroma. In preferred embodiments, a functional food composition comprises grapefruit or lemon aroma, more preferably a combination of grapefruit aroma and lemon aroma.
[0087] A functional food composition as disclosed herein preferably does not comprise additional artificial or natural sweeteners in addition to steviol glycosides and thaumatin or sucralose. In preferred embodiments, the composition does not comprise one or more of the following: acesulfame potassium, aspartame, monk fruit extract or glucose.
[0088] A functional food composition as disclosed herein further preferably does not comprise synthetic preservatives. In preferred embodiments, the composition does not comprise ascorbic acid, calcium disodium EDTA, potassium benzoate, potassium sorbate, or sulfite.
[0089] A functional food composition as disclosed herein further preferably does not comprise maltodextrin, potassium phosphate, potassium citrate, sodium phosphate, or sodium selenite.A functional food composition as disclosed herein may be in any form suitable for oral consumption, such as in a form of a powder, tablet, capsule, gel, or liquid. Preferably, the functional food composition is a solid composition. The solid composition may be in a form of tablet, capsule, powder, granules, pellets, agglomerates, lozenges.
[0090] Preferably, the solid composition is in a form of any one of powder, granule, pellets, tablet, or agglomerates, more preferably in a form of powder. Solid compositions such as powders, granules, agglomerates can be reconstituted with water or another aqueous liquid, such as tea, fruit juice, milk, milk -based drink such as buttermilk or kefir. Such reconstitution for instance results in a concentrated or ready-to-drink beverages or in a shake. Alternatively, the solid composition is mixed into a meal. In preferred embodiment, a functional food composition described herein is in a powdered form intended for reconstitution with water or another aqueous liquid.
[0091] A functional food composition as described herein may be provided in a sachet or a multi-dose container such as resealable pouch bags, plastic containers. When provided in a multi-dose container, the container is preferably provided with a scoop to ensure accurate dosing. In such cases, a scoop of the functional food composition may represent a single serving unit (single dose). Multi-dose container maybe advantageous when flexible dosing is required.
[0092] An individual may consume at least one serving unit of the functional food composition per day. In some embodiments, the individual may consume two, three, or even more serving units per day, preferably two serving units per day.
[0093] Preferably, a functional food composition is provided in a sachet. As used herein, the term “sachet” refers to a sealed packet or pouch designed to contain a single-dose quantity of a functional food composition as described herein such as in a form of powder, granules, or pellets. A sachet as disclosed herein comprises 3-6 g, preferably 4-5 g of a functional food composition as disclosed herein.
[0094] A sachet may be advantageous compared to multi-dose containers when stability and consistent dosing are required. In particular, the composition in multi-dose containers may be susceptible to repeated exposure to ambient air and moisture. A single-dosesachet offers enhanced product stafrility and extended shelflife. This is particularly advantageous for hygroscopic or oxidation-prone compounds such as NAC, as the individual packaging of each dose limits oxidative degradation Moreover, the internal atmosphere of each sachet may optionally be modified by replacing air with an inert gas such as nitrogen or argon, thereby minimizing exposure to oxygen and moisture and improving the long-term stability of the composition, particularly N-acetylcysteine (NAC). In addition to stability, sachets enable consistent and accurate dosing by eliminating the need for consumer measurement, thereby reducing the potential for under- or overdosing. The single-dose format of sachet also mitigates issues associated with clumping, commonly observed in bulk formulations due to cumulative air exposure.
[0095] Furthermore, sachets offer superior portability and user convenience, allowing for easy, on-the-go consumption without auxiliary equipment or need for measuring. The sealed, single-use design significantly reduces the risk of contamination, which may otherwise occur in bulk containers through repeated opening or contact with scoops, hands, or environmental moisture.
[0096] Alternatively, the disclosure provides a liquid beverage comprising 3-6 g, preferably 4-5 g of a functional food composition as disclosed herein. In another aspect, a method of preparing a liquid beverage as disclosed herein is provided. Said method comprises mixing a functional food composition as described herein with liquid, wherein the liquid beverage comprises 1g composition per 4- 100ml of liquid, preferably 1g composition per 6-25 ml of liquid. Preferably the liquid is water, fruit juice, milk, milk -based drink, or tea.
[0097] As described above a functional food composition as disclosed herein has an improved shelf-life or comparable shelf-life to currently available NAC and glycine composition without the need for synthetic preservatives. In some embodiments, the composition as disclosed herein has a shelflife of at least 6 months, at least 12 months, at least 18 months, preferably at least 24 months at room temperature. In some embodiments, the composition as disclosed herein can be stored for at least 6 months, at least 12months, at least 18 months, preferably at least 24 months at room temperature without measurable oxidation of NAC.
[0098] As described above, NAC and glycine offer numerous health benefits and are known in the art for their roles in mitigating oxidative stress, reducing low-grade inflammation, and preserving mitochondrial integrity. Accordingly, in an aspect the disclosure provides a functional food composition as disclosed herein for supporting physiological functions associated with healthy aging.
[0099] In particular, the disclosure provides methods for treating or preventing one or more medical disorders or conditions associated with aging in an individual. As used herein, the terms "treatment," "treat," and "treating" refer to reversing, alleviating, delaying the onset of, or inhibiting the progress of a disorder or condition, or one or more symptoms thereof, as described herein. In some embodiments, treatment may be administered after one or more symptoms have developed. In other embodiments, treatment may be administered in the absence of symptoms. For example, treatment may be a prophylactic treatment administered to an individual prior to the onset of symptoms.
[0100] In particular, the functional food compositions described herein are useful in methods of or treating or preventing one or more medical disorders or conditions associated with aging in an individual.
[0101] Preferably, the medical disorder or condition is associated with or is mitochondrial dysfunction, glutathione deficiency, low-grade inflammation, oxidative stress, insulin resistance, obesity, and / or endothelial dysfunction. More preferably the disorder or condition is selected from mitochondrial dysfunction, glutathione deficiency, or low-grade systemic inflammation.
[0102] An individual may be an adult individual, such as an elderly individual, particularly an elderly individual suffering from a muscle decline. As used herein, the term “elderly” refers to an individual over the age of at least 60 years. In someembodiments, an individual is at least 60 years, including at least 70 years, including at least 80 years.
[0103] Alternatively, the functional food composition as disclosed herein may be administered to healthy adult individuals to prevent one or more medical disorders or conditions associated with aging in an individual. Accordingly, an individual may be at least 30 years, at least 40 years, at least 45 years, at least 50 years, at least 55 years.
[0104] The uses of the present disclosure include continuous day- after- day administration, as well as periodic or limited administration, although continuous day-after-day administration is generally desirable. A composition for use of the present disclosure is preferably administered daily. Preferably, the daily administration is maintained continuously for at least 1 month, at least 2 months, at least 6 months, at least 12-24 months, desirably 3 year, including at least 5 year, including at least 10 years.
[0105] The functional food composition as disclosed herein may be administered daily at a dosage of 7-14 grams of the composition, preferably 8-12 grams of the composition. Specifically, the functional food composition as disclosed herein may be administered daily at a dosage of 2-5 grams of NAC, preferably 2.5-3 grams of NAC.
[0106] The disclosure further provides a method for preparing a composition as described herein, the method comprising the steps of:
[0107] - providing the mixture components described herein;
[0108] - mixing said components to obtain a uniform mixture.
[0109] A skilled person is aware of common techniques in the art for preparing solid compositions, such as powders, granules, pellets, tablet, agglomerates, etc. In general, the raw materials are weighed according to the specified composition and thereafter mixed together in a mixer.
[0110] The composition may be prepared by dry blending the components under standard low-humidity conditions, using appropriate mixing techniques to ensure homogeneous distribution. High-potency sweeteners may be pre-dispersed or blended with asuitable carrier to promote uniform mixing. The resulting blend may be filled into individual sachets for single-use administration.
[0111] Preferably, NAC is in a form of a fine powder to improve homogeneity of the final mixture and ensure good dissolution.
[0112] Further processing (e.g. pelleting, granulation) may be performed after the mixing step. The semi-finished product (e.g. powder, pellets), may be packed into appropriate packaging material, such as sachet as disclosed herein.
[0113] In addition to improved taste and odor profiles during storage and / or consumption, the composition as disclosed herein also provides a significantly improved user experience during preparation of liquid beverage comprising the functional food composition described herein, such as when reconstituting the functional food composition in water or another aqueous liquid. In conventional use, NAC is often added separately to acidic beverages (e.g., to mask its taste), which results in immediate release of a strong sulfurous odor during mixing. This effect is unpleasant and may discourage regular use.
[0114] It is within the purview of the skilled person to assess palatability, odor, and sensory acceptability. Suitable methods include organoleptic scoring, visual analogue scales (VAS), 11-point acceptability scales, blinded comparisons, triangle testing, and headspace volatile organic compound (VOC) analysis.
[0115] In contrast, the present functional food composition is designed for direct dissolution in water. When prepared as intended, it does not release a noticeable sulfur odor and is generally perceived as neutral or acceptable by users. This feature contributes to daily compliance and convenience, particularly in home use or clinical prevention settings.
[0116] This improved preparation experience may be attributed to the combination of glycine and NAC with proprietary blend including inter alia plant biomass (e.g. dried biomass of Spinacia genus and / or Chlorella genus) containing endogenous antioxidants and flavor-masking agents, as described above.In another aspect, the invention provides a method for stabilizing NAC in powdered form. The method comprises combining NAC with glycine and a proprietary blend comprising whole biomass materials such as dried spinach and / or Chlorella. These biomass materials contain naturally occurring antioxidants (e.g., polyphenols, carotenoids, chlorophyll derivatives), which are believed to contribute to reduced oxidation of NAC during storage as described above. Unlike conventional stabilization strategies that require purified additives such as ascorbic acid, this method allows for NAC stabilization using food-grade, unextracted biomass ingredients.
[0117] The invention is further explained in the following examples. These examples do not limit the scope of the invention, but merely serve to clarify the invention.
[0118] EXAMPLES
[0119] Example 1: Preparation of NAC and glycine composition
[0120] Three NAC and glycine compositions were prepared in a ratio of 1:1:1 for NAC: glycine: remaining substances (proprietary blend). Specific formulations 1, 2, and 3 (Fl, F2, F3) are as specified below. All percentages are by weight.
[0121]
[0122] Formulations 1, 2, and 3 were prepared by mixing small-volume substances first to ensure even distribution. The obtained final mixture had even distribution and nodifficulties were observed upon dissolving Formulations 1, 2, and 3 in a liquid at room temperature.
[0123] Example 2 - Oxidative stability under ambient storage
[0124] Two powdered compositions were prepared as described in Example 1 (Formulation 1 and 2), each comprising the same core ingredients, specifically glycine and NAC, but differing in for example sweeteners and flavorings used as specified under Example 1 A reference composition containing NAC alone, without glycine or plant biomass was also prepared.
[0125] Each composition was stored in sealed plastic bags or boxes under normal indoor conditions (approximately 15-30 °C, no direct light exposure). Samples of dry powdered form and of aqueous solutions of compositions were assessed at baseline and after 3 and 6 months for odor and appearance.
[0126] In both formulations (Formulation 1 and Formulation 2), no discoloration occurred, and sulfurous odor was consistently rated as absent or very faint by most observers. In contrast, the reference composition exhibited a strong and persistent sulfur odor, both in dry form and after dissolution, throughout the whole storage period (i.e. at baseline, after 3 month and after 6 months).
[0127] While individual perception varied — with some female observers reporting a faint residual odor for Formulations 1 and 2 — the overall sensory experience was markedly improved. The difference was especially noticeable during preparation of aqueous solution, where Formulations 1 and 2 dissolved without unpleasant odor release, whereas aqueous solution of NAC-only reference formulation or NAC added separately to acidic beverages (e.g., Fresca) produced an immediate and strong sulfur smell.
[0128] These observations support the hypothesis that the inclusion of whole plant biomass contributes to odor reduction and may stabilize NAC against oxidative degradation. The odor-masking effect cannot be attributed to glycine alone, as NAC is known to retain its sulfurous odor in formulations lacking additional stabilizing components. Further chemical stability testing (e.g., HPLC-based NAC / diNAC quantification) is planned.Example 3: Functional effects of NAC and glycine in combination with flavor-masking proprietary blend in aged mice
[0129] Study design
[0130] The effects of a composition comprising NAC, glycine, and a flavor-masking proprietary blend were evaluated in 90-week-old male C57BL / 6J mice, focusing on muscle strength and systemic inflammation. Sixteen mice were randomly assigned to two groups (n=8 per group). The treatment group received Formulation 1, as specified and prepared in Example 1. The control group received a control formulation, corresponding to Formulation 1 but without the addition of NAC and glycine (i.e., the flavor-masking proprietary blend alone).
[0131] The composition of the control formulation is as provided below.
[0132]
[0133] Formulation 1 and the control formulation were each admixed into standard Ssniff chow powder diet and administered orally. The treatment group received Formulation 1 at a concentration of 4.8 mg / g diet, while the control group received the control formulation at 1.8 mg / g diet. The diets were lyophilized, vacuum-sealed, and stored in the dark at -20°C. Diets were replaced weekly throughout the study.
[0134] In week 7, muscle strength was evaluated using a grip strength meter, measuring both two-paw and four-paw grip. Mice were placed on a grid connected to a digital force gauge and gently pulled by the tail until the maximum grip force was recorded. Maximum grip force is defined as the highest force exerted before the mouse released the grid.In week 8, blood was collected and plasma interleukin-6 (IL-6) levels were measured via enzyme -linked immunosorbent assay (ELISA). In addition, food intake was monitored weekly, and body weight was measured at baseline (week 0) and at weeks 1, 2, 7, and 8.
[0135] Results
[0136] Both groups of mice responded well to both formulations, exhibited normal behavior and showed no signs of abnormalities.
[0137] After seven weeks, the treatment group treated with Formulation 1 exhibited a significant 26% increase in normalized 2-paw grip strength compared to the control group (p=0.033) (Figure 1).
[0138] Additionally, a trend toward enhanced normalized 4-paw grip strength (+14%, p=0.067) was observed, suggesting broad improvements in physical function (Figure 2).
[0139] Mice treated with Formulation 1 exhibited suppressed inflammation. Particularly, plasma IL-6, a key marker of inflammation, was significantly reduced in the treatment group. While IL-6 levels were measurable in the control group, they were undetectable in the treatment group after eight weeks (p=0.019) as shown in Figure 3. Furthermore, a cumulative food intake in the treatment group was lower than in the control group, yet body weight and lean mass were maintained, suggesting potential metabolic benefits.
[0140] These findings demonstrate potential of novel NAC and glycine composition (Formulation 1) to replicate and validate key effects of NAC and glycine supplementation, specifically in improving muscle strength and reducing systemic inflammation. This study provides robust evidence supporting the feasibility of Formulation 1 as a next- generation intervention targeting hallmarks of aging, with the potential to enhance physical function and mitigate inflammation in aging populations.
[0141] Example 4: Sensory experience during preparation and consumption Three formulations were compared in terms of odor and taste, both during preparation and after dissolution:Reference solution A: A 2.5% (w / v) solution of NAC (N- acetylcysteine) in tap water
[0142] Reference solution B: NAC manually added to an acidified carbonated citrus beverage immediately before consumption
[0143] Solution C: A single-dose sachet of Formulation 1 (as specified and prepared in Example 1) dissolved in tap water to the same NAC concentration (2.5% w / v)
[0144] All solutions used the same batch of NAC. Observations focused on odor intensity during handling, ease of preparation of aqueous solutions, and taste upon consumption of said solutions. All preparations were performed by the test subjects themselves to mimic real- world use.
[0145] Reference solution A produced a strong sulfurous odor when the NAC powder was opened and mixed, and was perceived as highly unpleasant. The final solution had a sour and metallic taste.
[0146] Reference solution B also released a strong sulfurous odor during preparation, particularly while scooping NAC from the container and adding it to the beverage. While the resulting drink was rated as acceptable in taste, the preparation process was described as messy and offensive. The open NAC powder used in this method was not protected from oxidation during storage.
[0147] Solution C (prepared using Formulation 1) exhibited minimal odor upon opening and mixing. No sulfurous smell was released during preparation. The sachet contents dissolved cleanly in water and produced a mild citrus taste, perceived as neutral or pleasant by most testers.
[0148] Notably, a previous study (Crouch et al., 2007) evaluated the sensory properties of NAC dissolved in various beverages. However, that study did not assess the user experience during preparation. In real-world settings, where users prepare solutions themselves, exposure to unprotected NAC powder may result in strong unpleasant odor prior to consumption. The current composition minimizes exposure to the strong unpleasant prior and during consumption by delivering NAC in a stabilized matrix within a sealed sachet.
[0149] The sulfurous odor associated with NAC is primarily released during handling, and not only during dissolution. This odor is present even at lower NAC concentrations(e.g., <2.5% w / v), and the observed difference between reference solutions A / B and solution C is therefore not attributable to concentration alone.
[0150] Preliminary sensory scoring
[0151] A small informal test group (n=5) scored each solution on odor during preparation and taste after preparation using a 5-point scale (1 = none or pleasant, 5 = strong or unpleasant):
[0152]
[0153] The observed scores suggest that Formulation 1 and its corresponding solution C provide a substantial improvement in user experience, particularly during preparation of said solution. This difference may translate into improved long-term compliance in practical use. Similarly, the sensory characteristics of solution using Formulation 2 (as specified in Example 1) are expected to be very similar due to similar formulations.
[0154] While the present composition is preferably provided in pre-portioned sachets, the odor-masking and stabilizing effects were also observed when the same proprietary mix was stored in bulk containers and manually scooped. This suggests that the observed advantages are primarily conferred by the antioxidant-rich matrix within the proprietary blend and not solely dependent on packaging format.
Claims
Claims1. A functional food composition comprising:- N- acetylcysteine (NAC),- glycine,- a dried biomass of Spinacia genus and Chlorella genus,- Cinnamomum verum,- optionally grapefruit aroma,- lemon flavor,- rebaudioside M, and- thaumatin or sucralose.
2. The composition according to claim 1, wherein the composition comprises 20-40 wt.% of NAC, 20-40 wt.% of glycine, 3-35 wt.% of said dried biomass, 0.3-9 wt.% of Cinnamomum verum, 0.03-2 wt.% of grapefruit aroma, 0.03-2 wt.% of lemon flavor, 0.02-1.3 wt.% of rebaudioside M, and 0.025-0.667% of thaumatin.
3. The composition according to claim 1, wherein the composition comprises 20-40 wt.% of NAC, 20-40 wt.% of glycine, 3-35 wt.% of said dried biomass, 0.3-9 wt.% of Cinnamomum verum, 0-0.5% wt.% of grapefruit aroma, 0.03-2 wt.% of lemon flavor, 0.02-0.5 wt.% of rebaudioside M, and 0.1%-0.5% of sucralose.
4. The composition according to any one of the preceding claims, wherein the composition comprises between 20-40 wt.% of NAC, preferably between 25-35 wt.% of NAC, such as 33 wt.% of NAC.
5. The composition according to any one of the preceding claims, wherein the composition is a solid composition, preferably in a form of any one of powder, granule, pellets, tablet, or agglomerates.
6. The composition according to any one of the preceding claims, wherein the composition does not comprise one or more of the following: acesulfame potassium, ascorbic acid, aspartame, calcium disodium EDTA, glucose, sulfite, maltodextrin, monk fruit extract, potassium benzoate, potassium phosphate, potassium citrate, potassium sorbate, sodium phosphate, or sodium selenite.
7. The composition according to any one of the preceding claims, comprising N-acetylcysteine (NAC), glycine, a dried biomass of Spinacia genus and Chlorella genus, Cinnamomum verum, grapefruit aroma, lemon flavor, rebaudioside M, andthaumatin.
8. The composition according to any one of claims 1-6, comprising N-acetylcysteine (NAC), glycine, a dried biomass of Spinacia genus and Chlorella genus, Cinnamomum verum, lemon flavor, rebaudioside M, and sucralose.
9. A sachet comprising 3-6 g of the composition according to any one of claims 1-8, preferably 4-5 g of the composition according to any one of claims 1-8.
10. A liquid beverage comprising 3-6 g of the composition according to any one of claims 1-8, preferably 4-5 g of the composition according to any one of claims 1-8.
11. A method of preparing the liquid beverage of claim 10 comprising mixing the composition with liquid, wherein the liquid beverage comprises 1g composition per 4-100ml of liquid, preferably wherein the liquid is water, fruit juice, milk -based drink, or tea.
12. A non-therapeutic use of the composition of any one of the preceding claims for improving or supporting mitochondrial function, oxidative resilience, or healthy metabolic function in an individual.
13. The non-therapeutic use according to claim 12, wherein 7-14 grams of the composition is administered daily.
14. The composition according to any one of claims 1-8, wherein the composition is formulated for direct dissolution in water without release of unpleasant sulfurous odor during preparation.
15. A method of reducing oxidative degradation of N- acetylcysteine in a powdered food composition, comprising blending NAC and glycine with a dried biomass of Spinacia genus and Chlorella genus, Cinnamomum verum, optionally grapefruit aroma, lemon flavor, rebaudioside M, and thaumatin or sucralose.
16. A method of preparing a shelf-stable powdered functional food composition with improved palatability, the method comprising blending N-acetylcysteine and glycine with a dried biomass of Spinacia genus and Chlorella genus, Cinnamomum verum, optionally grapefruit aroma, lemon flavor, rebaudioside M, and thaumatin or sucralose.
